Spectrophotometric method for determination of bifunctional macrocyclic ligands in macrocyclic ligand-protein conjugates

被引:64
作者
Dadachova, E [1 ]
Chappell, LL [1 ]
Brechbiel, MW [1 ]
机构
[1] NCI, Radioimmune & Inorgan Chem Sect, Radiat Oncol Branch, NIH, Bethesda, MD 20892 USA
关键词
polyazamacrocycles; antibodies; spectrophotometry; radioimmunotherapy; radiolabeling; conjugates;
D O I
10.1016/S0969-8051(99)00054-2
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
A simple spectrophotometric assay for determination of bifunctional polyazacarboxylate-macrocyclic ligands of different sizes that are conjugated to proteins has been developed for: 12-membered macrocycle DOTA (2[4 nitrobenzyl]-1, 4, 7, 10-tetraazacyclododecane-N, N',N", N"'-tetraacetic acid) and analogs, the 15-membered PEPA macrocycle (2-[4-nitrobenzyl]-1,4,7,10,13-pentaazacyclopentadecane-N,N',N",N''',N""-pentaacetic acid), and the large 18 membered macrocycle HEHA (1,4,7,10,13,16-hexaazacyclooctadecane-N,N',N",N"',N"",N""'-pentaacetic acid). The method is based on titration of the blue-colored 1:1 Pb(II)-Arsenazo III (AAIII) complex with the polyazacarboxylate macrocyclic ligand in the concentration range of 0-2.5 mu M, wherein color change occurring upon transchelation of the Pb(II) from the AAIII to the polyazamacrocyclic ligand is monitored at 656 nm. The assay is performed at ambient temperature within 20 min without any interfering interaction between the protein and Pb(II)-AA(III) complex. Thus, this method also provides a ligand-to-protein ratio (VP ratio) that reflects the effective number of ligands per protein molecule available to radiolabeling. The method is not suitable for 14-membered TETA macrocycle 2-[4-nitrobenzyl]-1, 4, 8, 11-tetraazacyclotetradecane N,N',N",N"'-tetraacetic acid) because of low stability constant of Pb(II)-TETA complex. The method is rapid, simple and may be customized for other polyazacarboxylate macrocyclic ligands. Published by Elsevier Science Inc.
引用
收藏
页码:977 / 982
页数:6
相关论文
共 22 条
[1]  
ANDERSON CJ, 1994, J NUCL MED, V35, pP161
[2]  
CHAPPELL LL, UNPUB SYNTHESIS EVAL
[3]  
CHAPPELL LL, IN PRESS BIOORG MED
[4]  
CHAPPELL LL, UNPUB NUCL MED BIOL
[5]   THE STABILITY OF THE METAL-COMPLEXES OF CYCLIC TETRA-AZA TETRAACETIC ACIDS [J].
CHAVES, S ;
DELGADO, R ;
DASILVA, JJRF .
TALANTA, 1992, 39 (03) :249-254
[6]  
COLE WC, 1986, NUCL MED BIOL, V13, P363
[7]   Improved in vivo stability of actinium-225 macrocyclic complexes [J].
Deal, KA ;
Davis, IA ;
Mirzadeh, S ;
Kennel, SJ ;
Brechbiel, MW .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (15) :2988-2992
[8]   New anti-Cu-TETA and anti-Y-DOTA monoclonal antibodies for potential use in the pre-targeted delivery of radiopharmaceuticals to tumor [J].
Feng, X ;
Pak, RH ;
Kroger, LA ;
Moran, JK ;
DeNardo, DG ;
Meares, CF ;
DeNardo, GL ;
DeNardo, SJ .
HYBRIDOMA, 1998, 17 (02) :125-132
[9]   Isolation of cyclotron produced 205Bi, 206Bi and 203Pb using a lead-selective extraction chromatographic resin [J].
Henriksen, G ;
Hoff, P .
APPLIED RADIATION AND ISOTOPES, 1998, 49 (04) :357-359
[10]  
Horak E, 1997, J NUCL MED, V38, P1944